These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31391728)

  • 1. Evaluation of Circulating Plasma VEGF-A, ET-1 and Magnesium Levels as the Predictive Markers for Proliferative Diabetic Retinopathy.
    Niranjan G; Srinivasan AR; Srikanth K; Pruthu G; Reeta R; Ramesh R; Anitha R; Mohana Valli V
    Indian J Clin Biochem; 2019 Jul; 34(3):352-356. PubMed ID: 31391728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
    Zhu H; Shi CH
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum vascular endothelial growth factor is a biomolecular biomarker of severity of diabetic retinopathy.
    Ahuja S; Saxena S; Akduman L; Meyer CH; Kruzliak P; Khanna VK
    Int J Retina Vitreous; 2019; 5():29. PubMed ID: 31583119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association study of HIF-1α rs11549465 and VEGF rs3025039 genetic variants with diabetic retinopathy in Egyptian patients: crosslinks with angiogenic, inflammatory, and anti-inflammatory markers.
    Mohamed MK; Atef AA; Moemen LA; Abdel Azeem AA; Mohalhal IA; Taha AM
    J Genet Eng Biotechnol; 2022 Aug; 20(1):122. PubMed ID: 35969320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of laser photocoagulation on serum angiopoietin-1, angiopoietin-2, angiopoietin-1/angiopoietin-2 ratio, and soluble angiopoietin receptor Tie-2 levels in type 2 diabetic patients with proliferative diabetic retinopathy.
    You QY; Zhuge FY; Zhu QQ; Si XW
    Int J Ophthalmol; 2014; 7(4):648-53. PubMed ID: 25161936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF, apelin and HO-1 in diabetic patients with retinopathy: a correlation analysis.
    Wu R; Zhu Z; Zhou D
    BMC Ophthalmol; 2020 Aug; 20(1):326. PubMed ID: 32770964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of diabetic retinopathy, proliferative diabetic retinopathy and non-proliferative diabetic retinopathy in Asian T2DM patients: a systematic review and Meta-analysis.
    Yang QH; Zhang Y; Zhang XM; Li XR
    Int J Ophthalmol; 2019; 12(2):302-311. PubMed ID: 30809489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum fetuin-A levels are independently correlated with vascular endothelial growth factor and C-reactive protein concentrations in type 2 diabetic patients with diabetic retinopathy.
    Zhou ZW; Ju HX; Sun MZ; Fu QP; Chen HM; Ji HB; Ji F; Jiang DM
    Clin Chim Acta; 2016 Apr; 455():113-7. PubMed ID: 26851648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulated Serum Lipid Metabolism Promotes the Occurrence and Development of Diabetic Retinopathy Associated With Upregulated Circulating Levels of VEGF-A, VEGF-D, and PlGF.
    Zhang X; Qiu B; Wang Q; Sivaprasad S; Wang Y; Zhao L; Xie R; Li L; Kang W
    Front Med (Lausanne); 2021; 8():779413. PubMed ID: 34904074
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of NF-κB activation and VEGF gene polymorphisms in VEGF up regulation in non-proliferative and proliferative diabetic retinopathy.
    Choudhuri S; Chowdhury IH; Das S; Dutta D; Saha A; Sarkar R; Mandal LK; Mukherjee S; Bhattacharya B
    Mol Cell Biochem; 2015 Jul; 405(1-2):265-79. PubMed ID: 25956512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of various serum biomarkers with the severity of diabetic retinopathy.
    Nalini M; Raghavulu BV; Annapurna A; Avinash P; Chandi V; Swathi N; Wasim
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S451-S454. PubMed ID: 28420575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Angiopoietins and Tie-2 in Diabetic Retinopathy.
    Khalaf N; Helmy H; Labib H; Fahmy I; El Hamid MA; Moemen L
    Electron Physician; 2017 Aug; 9(8):5031-5035. PubMed ID: 28979738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of vascular endothelial growth factor levels in tears and serum among diabetic patients.
    Ang WJ; Zunaina E; Norfadzillah AJ; Raja-Norliza RO; Julieana M; Ab-Hamid SA; Mahaneem M
    PLoS One; 2019; 14(8):e0221481. PubMed ID: 31437234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitreous and plasma changes of endothelin-1, adrenomedullin and vascular endothelium growth factor in patients with proliferative diabetic retinopathy.
    Vingolo EM; Fragiotta S; Mafrici M; Cutini A; Marinelli C; Concistrè A; Iannucci G; Petramala L; Letizia C
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):662-668. PubMed ID: 28272719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low blood and vitreal BDNF, LXA4 and altered Th1/Th2 cytokine balance are potential risk factors for diabetic retinopathy.
    Kaviarasan K; Jithu M; Arif Mulla M; Sharma T; Sivasankar S; Das UN; Angayarkanni N
    Metabolism; 2015 Sep; 64(9):958-66. PubMed ID: 26004392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of serum apelin-13 associated with proliferative diabetic retinopathy in type 2 diabetic patients.
    Du JH; Li X; Li R; Xu L; Ma RR; Liu SF; Zhang Z; Sun HZ
    Int J Ophthalmol; 2014; 7(6):968-73. PubMed ID: 25540748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus.
    Shinoda K; Ishida S; Kawashima S; Wakabayashi T; Matsuzaki T; Takayama M; Shinmura K; Yamada M
    Br J Ophthalmol; 1999 Jul; 83(7):834-7. PubMed ID: 10381671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab.
    Bressler SB; Liu D; Glassman AR; Blodi BA; Castellarin AA; Jampol LM; Kaufman PL; Melia M; Singh H; Wells JA;
    JAMA Ophthalmol; 2017 Jun; 135(6):558-568. PubMed ID: 28448655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANGPTL-4 correlates with vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Lu Q; Zou W; Chen B; Zou C; Zhao M; Zheng Z
    Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1281-8. PubMed ID: 26483143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
    Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N
    Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.